Ulisse
UBM.MIUlisse Biomed S.p.A. Price (UBM.MI)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
21,569,800
(167.4618)%Cash Flow Statement
Ulisse Biomed S.p.A.Currency: EUR
| YEAR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -1,933,483.00
+0% |
-1,043,000.00
-46% |
275.00k
-126% |
-603,599.00
-319% |
-1,307,745.00
+117% |
-4,796,847.00
+267% |
|||||||||||||
| Depreciation And Amortiz... | 0.00 | 55.00k | 51.00k | 247.72k | 319.64k | 330.12k | |||||||||||||
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | 0.00 | -4,411.00 | -369,502.00 | 143.52k | 108.48k | 0.00 | |||||||||||||
| Accounts Payables | 0.00 | 0.00 | 141.70k | -70,184.00 | 2.30k | 674.63k | |||||||||||||
| Inventory | 0.00 | 32.00k | 12.00k | -20,213.00 | -40,857.00 | 0.00 | |||||||||||||
| Other Working Capital | 0.00 | 643.00k | -511,193.00 | 38.92k | 102.22k | 207.80k | |||||||||||||
| Other Non-Cash Items | 1.93M | -92,000.00 | -100,000.00 | 311.37k | 414.87k | 3.08M | |||||||||||||
| Net Cash Provided By Op... | 0.00
+0% |
-405,000.00
+0% |
-501,000.00
+24% |
-394,779.00
-21% |
-970,460.00
+146% |
-1,385,412.00
+43% |
|||||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | 0.00 | -63,000.00 | -108,000.00 | -955,710.00 | -227,919.00 | -98,564.00 | |||||||||||||
| Acquisitions Net | 0.00 | 0.00 | 372.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Purchases Of Investments | 0.00 | -97,000.00 | -1,000.00 | -2,300.00 | 0.00 | 0.00 | |||||||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | -372.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Other Investing Activities | 0.00 | -158,542.00 | -103,000.00 | -958,010.00 | -149,609.00 | 100.00 | |||||||||||||
| Net Cash Used For Inv... | 0.00
+0% |
-160,000.00
+0% |
-212,000.00
+33% |
-958,010.00
+352% |
-227,919.00
-76% |
-98,464.00
-57% |
|||||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | 0.00 | 1,000.00 | -2,231.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Common Stock Issued | 0.00 | 0.00 | 0.00 | 6.30M | 2.46k | 42.00 | |||||||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Dividends Paid | 0.00 | 0.00 | -20,714.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Other Financing Activities | 0.00 | 0.00 | 1.95k | 6.30M | 2.46k | 0.00 | |||||||||||||
| Net Cash Used/Provide... | 0.00
+0% |
1,000.00
+0% |
-21,000.00
-2,200% |
6.30M
-30,097% |
2.46k
-100% |
42.00
-98% |
|||||||||||||
| Effect Of Forex Changes... | 0.00 | -1,000.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Net Change In Cash | 0.00 | -565,000.00 | -733,000.00 | 4.95M | -1,195,918.00 | -1,483,833.00 | |||||||||||||
| Cash At Beginning Of Per... | 0.00 | 1.34M | 776.00k | 43.02k | 4.99M | 3.79M | |||||||||||||
| Cash At End Of Period | 0.00 | 776.00k | 43.00k | 4.99M | 3.79M | 2.31M | |||||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | 0.00 | -405,000.00 | -501,000.00 | -394,779.00 | -970,460.00 | -1,385,412.00 | |||||||||||||
| Capital Expenditure | 0.00 | -63,000.00 | -108,000.00 | -955,710.00 | -227,919.00 | -98,564.00 | |||||||||||||
| Free Cash Flow | 0.00
+0% |
-468,000.00
+0% |
-609,000.00
+30% |
-1,350,489.00
+122% |
-1,198,379.00
-11% |
-1,483,976.00
+24% |
|||||||||||||